Now available SORAFENIB

SORAFENIB tablets are a kinase inhibitor indicated for the treatment of:

• Unresectable hepatocellular carcinoma (1.1)
• Advanced renal cell carcinoma (1.2)
• Locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DTC) refractory to radioactive iodine treatment (1.3)

Please see full prescribing information here.